ETFs positioned on Hansoh Pharmaceutical Group Company Limited

Logo Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.
Employees
9,347
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
25.35CNY
Average target price
40.53CNY
Spread / Average Target
+59.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 3692 Stock
  4. ETFs Hansoh Pharmaceutical Group Company Limited